Compare PANL & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PANL | SGHT |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.4M | 309.6M |
| IPO Year | 2015 | 2021 |
| Metric | PANL | SGHT |
|---|---|---|
| Price | $8.38 | $8.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $9.00 | ★ $9.08 |
| AVG Volume (30 Days) | ★ 372.7K | 138.2K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ 28.16 |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $385,088,209.00 | $77,363,000.00 |
| Revenue This Year | $0.72 | $11.67 |
| Revenue Next Year | N/A | $10.39 |
| P/E Ratio | $23.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.56 | $3.19 |
| 52 Week High | $9.39 | $9.24 |
| Indicator | PANL | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 59.47 | 57.32 |
| Support Level | $7.99 | $7.85 |
| Resistance Level | $8.49 | $8.82 |
| Average True Range (ATR) | 0.23 | 0.37 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 64.93 | 36.70 |
Pangaea Logistics Solutions Ltd and its subsidiaries collectively, Pangaea or the Company, provide seaborne drybulk logistics and transportation services as well as terminal and stevedoring services. Pangaea utilizes its logistics expertise to service a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company's operating segments include the shipping segment: The Company's operating segments include the shipping segment and six terminal and stevedoring operating segments. The company operates in the USA, Germany, Canada, Singapore, the United Kingdom, and other countries, with maximum from the USA and others.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.